pentobarbital will decrease the extent or outcome of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Use of other treatment options is strongly suggested when linagliptin would be to be administered that has a CYP3A4 inducerpentobarbital will reduce the level or influence of cilostazol by impacting